US4356167A
(en)
*
|
1978-01-27 |
1982-10-26 |
Sandoz, Inc. |
Liposome drug delivery systems
|
IT1111367B
(it)
*
|
1978-11-17 |
1986-01-13 |
Serono Ist Farm |
Processo per la preparazione estemporanea di liposomi e liposomi cosi' ottenuti
|
ATE8584T1
(de)
|
1980-01-16 |
1984-08-15 |
Hans Georg Prof. Dr. Weder |
Verfahren und dialysiereinrichtung zur herstellung von bilayer-vesikeln und verwendung der bilayer-vesikel.
|
US4302459A
(en)
*
|
1980-03-19 |
1981-11-24 |
The United States Of America As Represented By The Secretary Of The Army |
Liposome carriers in leishmaniasis chemotherapy with 8-aminoquinoline derivatives
|
EP0043327B1
(fr)
*
|
1980-07-01 |
1984-01-18 |
L'oreal |
Procédé d'obtention de dispersions stables dans une phase aqueuse d'au moins une phase liquide non miscible à l'eau et dispersions correspondantes
|
DE3173713D1
(en)
*
|
1980-09-05 |
1986-03-20 |
Frappier Armand Inst |
Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
|
US4394372A
(en)
*
|
1980-12-22 |
1983-07-19 |
The Procter & Gamble Company |
Process for making lipid membrane structures
|
GR77320B
(US06444660-20020903-C00009.png)
*
|
1980-12-22 |
1984-09-11 |
Procter & Gamble |
|
EP0072234B1
(en)
*
|
1981-08-10 |
1986-02-26 |
The Wellcome Foundation Limited |
Pharmaceutical formulations containing antimony
|
NL193099C
(nl)
*
|
1981-10-30 |
1998-11-03 |
Novo Industri As |
Gestabiliseerde insuline-oplossing.
|
EP0088046B1
(de)
*
|
1982-02-17 |
1987-12-09 |
Ciba-Geigy Ag |
Lipide in wässriger Phase
|
US4416872A
(en)
*
|
1982-03-17 |
1983-11-22 |
The United States Of America As Represented By The Secretary Of The Army |
Treatment of malaria with liposomes containing 8-aminoquinoline derivatives and glycoconjugates
|
AU564876B2
(en)
*
|
1982-03-29 |
1987-08-27 |
Liposome Company, Inc., The |
Stable plurilamellar vesicles
|
US4522803A
(en)
*
|
1983-02-04 |
1985-06-11 |
The Liposome Company, Inc. |
Stable plurilamellar vesicles, their preparation and use
|
US5441745A
(en)
*
|
1982-03-30 |
1995-08-15 |
Vestar, Inc. |
Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
|
US5435989A
(en)
|
1982-03-30 |
1995-07-25 |
Vestar, Inc. |
Method of targeting a specific location in a body
|
US4425334A
(en)
|
1982-04-02 |
1984-01-10 |
The Regents Of The University Of California |
Functional oxygen transport system
|
US4612370A
(en)
*
|
1982-04-02 |
1986-09-16 |
The Regents Of The University Of California |
Lipid-saccharide reaction products
|
US4522811A
(en)
*
|
1982-07-08 |
1985-06-11 |
Syntex (U.S.A.) Inc. |
Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
|
EP0100964A3
(de)
*
|
1982-07-31 |
1984-06-13 |
Reifenrath, Rainer, Dr. |
Pharmazeutisches Erzeugnis zur Behandlung und Prophylaxe von Infektionen sowie von Husten und obstruktiven Atemwegserkrankungen sowie Verfahren zu seiner Herstellung
|
US4485054A
(en)
*
|
1982-10-04 |
1984-11-27 |
Lipoderm Pharmaceuticals Limited |
Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
|
US4501728A
(en)
*
|
1983-01-06 |
1985-02-26 |
Technology Unlimited, Inc. |
Masking of liposomes from RES recognition
|
FR2540381B1
(fr)
*
|
1983-02-08 |
1986-05-30 |
Dior Sa Parfums Christian |
Procede pour stimuler la croissance des cellules; composition cosmetique, pharmaceutique et composition complementaire pour milieu de culture cellulaire appliquant ce procede
|
US5387410A
(en)
*
|
1983-03-18 |
1995-02-07 |
Mallinckrodt, Inc. |
Method for enhancing magnetic resonance with compositions containing paramagnetic elements carried by liposomes
|
US4588578A
(en)
*
|
1983-08-08 |
1986-05-13 |
The Liposome Company, Inc. |
Lipid vesicles prepared in a monophase
|
US5186941A
(en)
*
|
1983-05-06 |
1993-02-16 |
Vestar, Inc. |
Vesicle formulation for the controlled release of therapeutic agents
|
FR2561101B1
(fr)
*
|
1984-03-13 |
1986-10-31 |
Paris Sud Universite |
Procede de preparation de liposomes et liposomes ainsi obtenus
|
US4610868A
(en)
*
|
1984-03-20 |
1986-09-09 |
The Liposome Company, Inc. |
Lipid matrix carriers for use in drug delivery systems
|
US5231112A
(en)
*
|
1984-04-12 |
1993-07-27 |
The Liposome Company, Inc. |
Compositions containing tris salt of cholesterol hemisuccinate and antifungal
|
US4921706A
(en)
*
|
1984-11-20 |
1990-05-01 |
Massachusetts Institute Of Technology |
Unilamellar lipid vesicles and method for their formation
|
US4857319A
(en)
*
|
1985-01-11 |
1989-08-15 |
The Regents Of The University Of California |
Method for preserving liposomes
|
US4707453A
(en)
*
|
1985-04-05 |
1987-11-17 |
Becton Dickinson And Company |
Vesicle including a metal marker for use in an assay
|
US4698263A
(en)
*
|
1985-05-23 |
1987-10-06 |
Becton Dickinson And Company |
Sac having a marker linked thereto
|
US5409704A
(en)
*
|
1985-06-26 |
1995-04-25 |
The Liposome Company, Inc. |
Liposomes comprising aminoglycoside phosphates and methods of production and use
|
US4861580A
(en)
*
|
1985-10-15 |
1989-08-29 |
The Liposome Company, Inc. |
Composition using salt form of organic acid derivative of alpha-tocopheral
|
US5041278A
(en)
*
|
1985-10-15 |
1991-08-20 |
The Liposome Company, Inc. |
Alpha tocopherol-based vesicles
|
FR2591105B1
(fr)
|
1985-12-11 |
1989-03-24 |
Moet Hennessy Rech |
Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
|
JPH0751496B2
(ja)
*
|
1986-04-02 |
1995-06-05 |
武田薬品工業株式会社 |
リポソ−ムの製造法
|
FR2597345B1
(fr)
*
|
1986-04-22 |
1990-08-03 |
Oreal |
Composition cosmetique ou pharmaceutique a base d'une dispersion aqueuse de spherules lipidiques.
|
US6759057B1
(en)
|
1986-06-12 |
2004-07-06 |
The Liposome Company, Inc. |
Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
|
DE3776763D1
(US06444660-20020903-C00009.png)
*
|
1986-06-16 |
1992-03-26 |
The Liposome Co.,Inc., Princeton, N.J., Us |
|
US5204112A
(en)
*
|
1986-06-16 |
1993-04-20 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
US5252263A
(en)
*
|
1986-06-16 |
1993-10-12 |
The Liposome Company, Inc. |
Induction of asymmetry in vesicles
|
DE3777640D1
(US06444660-20020903-C00009.png)
*
|
1986-11-28 |
1992-04-23 |
The Liposome Co.,Inc., Princeton, N.J., Us |
|
US4783220A
(en)
*
|
1986-12-18 |
1988-11-08 |
Xerox Corporation |
Vesicle ink compositions
|
WO1988004573A1
(en)
*
|
1986-12-23 |
1988-06-30 |
The Liposome Company, Inc. |
Liposome preparation and antibiotic
|
US5723147A
(en)
*
|
1987-02-23 |
1998-03-03 |
Depotech Corporation |
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
GB8704171D0
(en)
*
|
1987-02-23 |
1987-04-01 |
Clayton Found Res |
Multivesicular liposomes
|
US4963297A
(en)
*
|
1987-12-22 |
1990-10-16 |
The Liposome Company, Inc. |
Spontaneous vesticulation of multilamellar liposomes
|
US5616334A
(en)
*
|
1987-03-05 |
1997-04-01 |
The Liposome Company, Inc. |
Low toxicity drug-lipid systems
|
US6406713B1
(en)
|
1987-03-05 |
2002-06-18 |
The Liposome Company, Inc. |
Methods of preparing low-toxicity drug-lipid complexes
|
MX9203808A
(es)
*
|
1987-03-05 |
1992-07-01 |
Liposome Co Inc |
Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
|
US5925375A
(en)
*
|
1987-05-22 |
1999-07-20 |
The Liposome Company, Inc. |
Therapeutic use of multilamellar liposomal prostaglandin formulations
|
MX9203804A
(es)
*
|
1987-10-19 |
1992-07-01 |
Liposome Co Inc |
Sistemas farmaceuticos a base de tocoferol.
|
US5017501A
(en)
*
|
1987-11-25 |
1991-05-21 |
Abbott Laboratories |
Preparation of uniformly sized liposomes encapsulating an aqueous liquid
|
US4873035A
(en)
*
|
1987-11-25 |
1989-10-10 |
Abbott Laboratories |
Preparation of sized populations of liposomes
|
KR900000848B1
(ko)
*
|
1987-12-30 |
1990-02-17 |
태평양화학 주식회사 |
리포좀을 함유한 화장료의 제조방법
|
US5807572A
(en)
*
|
1988-02-18 |
1998-09-15 |
Depotech Corporation |
Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
|
US5013497A
(en)
*
|
1988-03-03 |
1991-05-07 |
Micro-Pak, Inc. |
Method and apparatus for producing lipid vesicles
|
US5948441A
(en)
*
|
1988-03-07 |
1999-09-07 |
The Liposome Company, Inc. |
Method for size separation of particles
|
US5422120A
(en)
*
|
1988-05-30 |
1995-06-06 |
Depotech Corporation |
Heterovesicular liposomes
|
CA1339034C
(en)
*
|
1988-08-22 |
1997-04-01 |
Paul A. Tremblay |
Platinum complexes of single isomer neoalkyl acids
|
US4906476A
(en)
*
|
1988-12-14 |
1990-03-06 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs in lungs
|
US5043165A
(en)
*
|
1988-12-14 |
1991-08-27 |
Liposome Technology, Inc. |
Novel liposome composition for sustained release of steroidal drugs
|
US5116615A
(en)
*
|
1989-01-27 |
1992-05-26 |
Immunolytics, Inc. |
Method for treating benign prostatic hypertrophy
|
EP0456724B1
(en)
|
1989-01-27 |
1995-05-03 |
Immunolytics, Inc. |
Composition and method for treating benign prostatic hypertrophy
|
US5078986A
(en)
*
|
1989-02-15 |
1992-01-07 |
Mallinckrodt Medical, Inc. |
Method for enhancing magnetic resonance imaging using an image altering agent containing an excess of chelating agent
|
US5100662A
(en)
*
|
1989-08-23 |
1992-03-31 |
The Liposome Company, Inc. |
Steroidal liposomes exhibiting enhanced stability
|
US5227165A
(en)
*
|
1989-11-13 |
1993-07-13 |
Nova Pharmaceutical Corporation |
Liposphere delivery systems for local anesthetics
|
IE904098A1
(en)
*
|
1989-11-13 |
1991-05-22 |
Nova Pharm Corp |
Lipospheres for controlled delivery of substances
|
US5221535A
(en)
*
|
1989-11-13 |
1993-06-22 |
Nova Pharmaceutical Corporation |
Sustained release formulations of insect repellent
|
US5188837A
(en)
*
|
1989-11-13 |
1993-02-23 |
Nova Pharmaceutical Corporation |
Lipsopheres for controlled delivery of substances
|
US5705187A
(en)
*
|
1989-12-22 |
1998-01-06 |
Imarx Pharmaceutical Corp. |
Compositions of lipids and stabilizing materials
|
US5585112A
(en)
*
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
US5305757A
(en)
*
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US6146657A
(en)
*
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US6001335A
(en)
*
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US5580575A
(en)
*
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US20020150539A1
(en)
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
US5656211A
(en)
*
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US5733572A
(en)
*
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
US5542935A
(en)
*
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5922304A
(en)
*
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
ZA911974B
(en)
*
|
1990-03-21 |
1994-08-22 |
Res Dev Foundation |
Heterovesicular liposomes
|
US20010024638A1
(en)
*
|
1992-11-02 |
2001-09-27 |
Michel Schneider |
Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
|
US6613306B1
(en)
|
1990-04-02 |
2003-09-02 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
US7083778B2
(en)
*
|
1991-05-03 |
2006-08-01 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
US5445813A
(en)
*
|
1992-11-02 |
1995-08-29 |
Bracco International B.V. |
Stable microbubble suspensions as enhancement agents for ultrasound echography
|
US6989141B2
(en)
*
|
1990-05-18 |
2006-01-24 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
IN172208B
(US06444660-20020903-C00009.png)
*
|
1990-04-02 |
1993-05-01 |
Sint Sa |
|
USRE39146E1
(en)
|
1990-04-02 |
2006-06-27 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
US5578292A
(en)
|
1991-11-20 |
1996-11-26 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
US20040208826A1
(en)
*
|
1990-04-02 |
2004-10-21 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
AU636481B2
(en)
*
|
1990-05-18 |
1993-04-29 |
Bracco International B.V. |
Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
|
US20030194376A1
(en)
*
|
1990-05-18 |
2003-10-16 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
CA2087965A1
(en)
*
|
1990-07-30 |
1992-02-01 |
Ajoy Chakrabarti |
Accumulation of amino acids and peptides into liposomes
|
ES2089226T3
(es)
*
|
1990-09-06 |
1996-10-01 |
Johnson & Son Inc S C |
Procedimiento para estabilizar liposomas y composiciones que los contienen.
|
US5874062A
(en)
*
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5205290A
(en)
*
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US5567432A
(en)
*
|
1991-08-02 |
1996-10-22 |
Lau; John R. |
Masking of liposomes from RES recognition
|
IL104084A
(en)
|
1992-01-24 |
1996-09-12 |
Bracco Int Bv |
Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
|
US5455044A
(en)
*
|
1993-05-14 |
1995-10-03 |
Depotech Corporation |
Method for treating neurological disorders
|
DE1118326T1
(de)
*
|
1993-05-21 |
2002-04-18 |
Liposome Co Inc |
Reduzierung von durch Liposomen induzierten physiologischen Gegenreaktionen
|
CN1099868C
(zh)
*
|
1993-11-16 |
2003-01-29 |
斯卡法玛公司 |
具有控制释放活性成分作用的囊
|
US7083572B2
(en)
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
PL182223B1
(pl)
|
1993-12-15 |
2001-11-30 |
Bracco Research Sa |
Biokompatybilna faza rozproszona do otrzymywania srodka kontrastowego do badan ultradzwiekowych, srodek kontrastowy do badan ultradzwiekowych, suchy preparat srodka kontrastowego oraz dwuskladnikowy zestaw do otrzymywania srodka kontrastowego do badan ultradzwiekowych PL PL PL
|
DE69530914T2
(de)
*
|
1994-02-17 |
2004-03-11 |
New York Blood Center, Inc. |
Biologische bioadhäsive präparate, die fibrinkleber und liposomen enthalten, verfahren für ihre herstellung und verwendung
|
US5736121A
(en)
*
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
US6455304B1
(en)
*
|
1994-07-01 |
2002-09-24 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronate synthase gene and uses thereof
|
US7091008B1
(en)
|
1994-07-01 |
2006-08-15 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthase genes and expression thereof in Bacillus hosts
|
US6951743B2
(en)
|
1997-10-31 |
2005-10-04 |
University Of Oklahoma Board Of Regents |
Hyaluronan synthase genes and expression thereof in bacillus hosts
|
US5993850A
(en)
*
|
1994-09-13 |
1999-11-30 |
Skyepharma Inc. |
Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US5830430A
(en)
*
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
US5800833A
(en)
*
|
1995-02-27 |
1998-09-01 |
University Of British Columbia |
Method for loading lipid vesicles
|
US5824638A
(en)
*
|
1995-05-22 |
1998-10-20 |
Shire Laboratories, Inc. |
Oral insulin delivery
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US6139819A
(en)
*
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US6033645A
(en)
*
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
CA2227013A1
(en)
|
1995-07-14 |
1997-02-06 |
Glycotech Corp. |
Compounds and methods for treatment of egf receptor associated cancers and purification of the egf receptor
|
US5931809A
(en)
|
1995-07-14 |
1999-08-03 |
Depotech Corporation |
Epidural administration of therapeutic compounds with sustained rate of release
|
US6022500A
(en)
*
|
1995-09-27 |
2000-02-08 |
The United States Of America As Represented By The Secretary Of The Army |
Polymer encapsulation and polymer microsphere composites
|
US6447800B2
(en)
|
1996-01-18 |
2002-09-10 |
The University Of British Columbia |
Method of loading preformed liposomes using ethanol
|
US6143287A
(en)
*
|
1996-02-27 |
2000-11-07 |
New York Blood Center, Inc. |
Method and composition for hair removal
|
WO1997040679A1
(en)
|
1996-05-01 |
1997-11-06 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
JP4139440B2
(ja)
*
|
1996-09-11 |
2008-08-27 |
イマアーレクス・フアーマシユーチカル・コーポレーシヨン |
造影剤及び血管拡張薬を用いる画像診断のための改良された方法
|
US5846517A
(en)
*
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
US5997899A
(en)
|
1996-10-01 |
1999-12-07 |
Skyepharma Inc. |
Method for producing liposomes with increased percent of compound encapsulated
|
US5891467A
(en)
|
1997-01-31 |
1999-04-06 |
Depotech Corporation |
Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6090800A
(en)
*
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US7452551B1
(en)
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
DE69841002D1
(de)
*
|
1997-05-14 |
2009-09-03 |
Univ British Columbia |
Hochwirksame verkapselung von nukleinsäuren in lipidvesikeln
|
EP2113247A3
(en)
|
1997-05-14 |
2010-05-05 |
The University Of British Columbia |
High efficiency encapsulation of nucleic acids in lipid vesicles
|
US6123956A
(en)
*
|
1997-07-10 |
2000-09-26 |
Keith Baker |
Methods for universally distributing therapeutic agents to the brain
|
US6306432B1
(en)
|
1997-09-08 |
2001-10-23 |
Chiron Corporation |
High and low load formulations of IGF-I in multivesicular liposomes
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
IL135060A
(en)
*
|
1997-09-18 |
2005-12-18 |
Skyepharma Inc |
Sustained release liposomal anesthetic compositions and methods for the preparation thereof
|
DK1025211T3
(da)
*
|
1997-10-31 |
2005-04-04 |
Univ Oklahoma |
Hyaluronansyntasegen og anvendelser deraf
|
CN101113436B
(zh)
*
|
1997-10-31 |
2013-02-06 |
俄克拉何马大学董事会 |
透明质酸合酶基因及其应用
|
EP1030652B1
(en)
*
|
1997-11-14 |
2012-04-25 |
Pacira Pharmaceuticals, Inc. |
Production of multivesicular liposomes
|
US6123923A
(en)
*
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
US6727079B1
(en)
*
|
1998-02-25 |
2004-04-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
cDNA encoding a gene BOG (B5T Over-expressed Gene) and its protein product
|
US7223571B2
(en)
*
|
1998-04-02 |
2007-05-29 |
The Board Of Regents Of The Universtiy Of Oklahoma |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
US20060188966A1
(en)
*
|
1998-04-02 |
2006-08-24 |
Deangelis Paul L |
Natural, chimeric and hybrid glycosaminoglycan polymers and methods of making and using same
|
US6987023B2
(en)
*
|
1998-04-02 |
2006-01-17 |
The Board Of Regents Of The University Of Oklahoma |
DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use
|
US20080108110A1
(en)
*
|
1998-04-02 |
2008-05-08 |
Deangelis Paul L |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
US7169410B1
(en)
|
1998-05-19 |
2007-01-30 |
Sdg, Inc. |
Targeted liposomal drug delivery system
|
US7094581B2
(en)
*
|
1998-10-26 |
2006-08-22 |
The Board Of Regents Of The University Of Oklahoma |
Hyaluronan synthases and methods of making and using same
|
EP1265849B1
(en)
|
2000-03-23 |
2006-10-25 |
Elan Pharmaceuticals, Inc. |
Compounds and methods to treat alzheimer's disease
|
US6992081B2
(en)
|
2000-03-23 |
2006-01-31 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
US20050287638A1
(en)
*
|
2000-04-25 |
2005-12-29 |
Weigel Paul H |
Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same
|
US6846813B2
(en)
*
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
US20030096864A1
(en)
*
|
2000-06-30 |
2003-05-22 |
Fang Lawrence Y. |
Compounds to treat alzheimer's disease
|
KR20030058959A
(ko)
*
|
2000-06-30 |
2003-07-07 |
엘란 파마슈티칼스, 인크. |
알츠하이머병을 치료하기 위한 화합물
|
CA2427467C
(en)
*
|
2000-11-09 |
2010-01-12 |
Neopharm, Inc. |
Sn-38 lipid complexes and methods of use
|
US20110301569A1
(en)
|
2001-01-20 |
2011-12-08 |
Gordon Wayne Dyer |
Methods and apparatus for the CVCS
|
US20020150566A1
(en)
*
|
2001-03-23 |
2002-10-17 |
Kun-Liang Guan |
Method of inhibiting cancerous cell proliferation using Ras mutants of GDP-bound conformation
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
JP2005500319A
(ja)
*
|
2001-06-27 |
2005-01-06 |
イーラン ファーマスーティカルズ、インコーポレイテッド |
アルツハイマー病の治療に有用なβ−ヒドロキシアミン誘導体
|
US20030068361A1
(en)
*
|
2001-10-09 |
2003-04-10 |
Rimona Margalit |
Liposome-encapsulated insulin formulations
|
BRPI0105509B8
(pt)
|
2001-11-05 |
2021-05-25 |
Univ Minas Gerais |
formulações do peptídeo angiotensina-(1-7) usando as ciclodextrinas, lipossomas e o polímero plga
|
CA2472055A1
(en)
*
|
2001-11-07 |
2003-05-15 |
Inex Pharmaceuticals Corporation |
Improved mucosal vaccines and methods for using the same
|
US7476400B2
(en)
*
|
2001-11-13 |
2009-01-13 |
Ferndale Ip, Inc. |
High-concentration lidocaine compositions and methods for their preparation
|
US20070020737A1
(en)
*
|
2001-12-03 |
2007-01-25 |
Pummill Philip E |
Hyaluronan synthases and methods of making and using same
|
US20030134423A1
(en)
*
|
2002-01-04 |
2003-07-17 |
Chu Yong Liang |
Compounds for delivering substances into cells
|
CA2471960A1
(en)
*
|
2002-01-09 |
2003-07-24 |
Elan Pharmaceuticals, Inc. |
Efficient liposomal encapsulation
|
US20030180348A1
(en)
*
|
2002-03-22 |
2003-09-25 |
Levinson R. Saul |
Transcellular drug delivery system
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
US20040009943A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Pathogen vaccines and methods for using the same
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
WO2004035032A2
(en)
*
|
2002-08-20 |
2004-04-29 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
ES2686361T3
(es)
|
2002-10-29 |
2018-10-17 |
Insmed Incorporated |
Liposomas que comprenden un aminoglucósido para el tratamiento de infecciones pulmonares
|
CN100377704C
(zh)
*
|
2002-11-26 |
2008-04-02 |
吉里德科学公司 |
脂质体制剂
|
US6866856B2
(en)
*
|
2002-12-31 |
2005-03-15 |
Avon Products, Inc. |
Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis
|
EP1695696A1
(en)
*
|
2003-12-01 |
2006-08-30 |
Mitsubishi Pharma Corporation |
Liposome
|
US7504385B2
(en)
*
|
2003-12-17 |
2009-03-17 |
Avon Products, Inc. |
si-RNA-mediated gene silencing technology to inhibit tyrosinase and reduce pigmentation
|
ES2388064T3
(es)
|
2004-04-22 |
2012-10-08 |
Celator Pharmaceuticals, Inc. |
Formulaciones liposomales de agentes de antraciclina y análogos de citidina
|
JP2008506780A
(ja)
|
2004-07-19 |
2008-03-06 |
セレーター ファーマスーティカルズ、インク. |
活性剤放出のための粒子状構築物
|
CA2584279C
(en)
|
2004-11-05 |
2015-01-27 |
Index Pharmaceuticals Corporation |
Compositions and methods for stabilizing liposomal drug formulations
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
US9944713B2
(en)
|
2004-11-24 |
2018-04-17 |
Medicinal Bioconvergence Research Center |
Antibody specific to the AIMP2-DX2
|
US7459529B2
(en)
|
2004-11-24 |
2008-12-02 |
Seoul National University Industry Foundation |
AIMP2-DX2 and its uses
|
AU2005318928B2
(en)
*
|
2004-12-20 |
2010-06-03 |
Australian Nuclear Science & Technology Organisation |
Controlled release of biological entities
|
MX2007007373A
(es)
*
|
2004-12-20 |
2007-08-14 |
Australian Nuclear Science Tec |
Liberacion controlada de entidades biologicas.
|
WO2006133518A1
(en)
*
|
2005-06-17 |
2006-12-21 |
Australian Nuclear Science And Technology Organisation |
Particles having hydrophobic material therein
|
MX2007016050A
(es)
*
|
2005-06-17 |
2008-03-10 |
Australian Nuclear Science Tec |
Particulas que comprenden un dopante que se puede liberar en las mismas.
|
AU2006257727B2
(en)
*
|
2005-06-17 |
2010-09-09 |
Encap Hive Pty Ltd |
Particles comprising a releasable dopant therein
|
AU2006257726B2
(en)
*
|
2005-06-17 |
2010-09-09 |
Australian Nuclear Science And Technology Organisation |
Particles having hydrophobic material therein
|
WO2007032225A1
(ja)
*
|
2005-09-15 |
2007-03-22 |
Kyoto University |
リポソーム、リポソームの製造方法及び微小反応空間内での反応制御方法
|
CA2628300C
(en)
|
2005-11-02 |
2018-04-17 |
Protiva Biotherapeutics, Inc. |
Modified sirna molecules and uses thereof
|
US9107824B2
(en)
|
2005-11-08 |
2015-08-18 |
Insmed Incorporated |
Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
|
US9149543B2
(en)
*
|
2005-12-15 |
2015-10-06 |
The Trustees Of The University Of Pennsylvania |
Methods and models for rapid, widespread delivery of genetic material to the CNS using non-viral, cationic lipid-mediated vectors
|
US20080094573A1
(en)
*
|
2006-04-04 |
2008-04-24 |
Vermette Patrick |
Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof
|
CA2663580C
(en)
*
|
2006-09-18 |
2015-03-17 |
Compugen Ltd |
Bioactive peptides and method of using same
|
EP2690178B1
(en)
|
2006-10-03 |
2021-12-22 |
The Board Of Regents Of The University Of Oklahoma |
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using same
|
WO2008130641A1
(en)
*
|
2007-04-20 |
2008-10-30 |
Biocure, Inc. |
Drug delivery vehicle containing vesicles in a hydrogel base
|
JP5355561B2
(ja)
|
2007-07-12 |
2013-11-27 |
コンピュゲン エルティーディー. |
生物活性ペプチドおよびその使用方法
|
ITRM20070394A1
(it)
*
|
2007-07-16 |
2009-01-17 |
Uni Cattolica Del Sacro Cuo Re |
Liposomi asimmetrici e loro usi in campo medico.
|
EP2187869B1
(en)
|
2007-08-17 |
2015-10-14 |
Celator Pharmaceuticals, Inc. |
Improved platinum drug formulations
|
EP4074344A1
(en)
|
2007-12-04 |
2022-10-19 |
Arbutus Biopharma Corporation |
Targeting lipids
|
EP2229583B1
(en)
|
2007-12-06 |
2019-04-10 |
Genalyte Inc. |
Label-free nucleic acid synthesis monitoring system and method
|
EP2231190B1
(en)
*
|
2007-12-06 |
2012-09-26 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Particulate drug carriers as desensitizing agents
|
ES2535419T3
(es)
|
2007-12-27 |
2015-05-11 |
Protiva Biotherapeutics Inc. |
Silenciamiento de expresión de quinasa tipo polo usando ARN interferente
|
EP3100718B1
(en)
|
2008-01-02 |
2019-11-27 |
Arbutus Biopharma Corporation |
Improved compositions and methods for the delivery of nucleic acids
|
PL2279254T3
(pl)
|
2008-04-15 |
2017-11-30 |
Protiva Biotherapeutics Inc. |
Nowe preparaty lipidowe do dostarczania kwasów nukleinowych
|
CA2721380A1
(en)
|
2008-04-15 |
2009-10-22 |
Protiva Biotherapeutics, Inc. |
Silencing of csn5 gene expression using interfering rna
|
JP5752598B2
(ja)
*
|
2008-09-11 |
2015-07-22 |
アイ.ビー.アール. イスラエリ バイオテクノロジー リサーチ リミテッド |
レウコユム球根の抽出物及びその利用
|
CA2984026C
(en)
|
2008-10-09 |
2020-02-11 |
Arbutus Biopharma Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
WO2010062627A2
(en)
|
2008-10-27 |
2010-06-03 |
Genalyte Inc. |
Biosensors based on optical probing and sensing
|
EA037404B1
(ru)
|
2008-11-10 |
2021-03-24 |
Арбутус Биофарма Корпорэйшн |
Липиды и композиции для доставки лекарственных средств
|
CA3036963A1
(en)
|
2009-01-29 |
2010-08-05 |
Arbutus Biopharma Corporation |
Lipid formulations comprising cationic lipid and a targeting lipid comprising n-acetyl galactosamine for delivery of nucleic acid
|
EP2395977A2
(en)
|
2009-02-11 |
2011-12-21 |
Lyka Labs Limited |
Liposomal citicoline injection
|
AU2010223967B2
(en)
|
2009-03-12 |
2015-07-30 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
|
JP5487666B2
(ja)
*
|
2009-03-23 |
2014-05-07 |
コニカミノルタ株式会社 |
内水相を固定化することを特徴とするリポソームの製造方法
|
AU2010245933B2
(en)
|
2009-05-05 |
2016-06-16 |
Arbutus Biopharma Corporation |
Methods of delivering oligonucleotides to immune cells
|
NZ596186A
(en)
|
2009-05-05 |
2014-03-28 |
Alnylam Pharmaceuticals Inc |
Lipid compositions
|
NZ712719A
(en)
|
2009-06-10 |
2017-03-31 |
Arbutus Biopharma Corp |
Improved lipid formulation
|
IL292615B2
(en)
|
2009-07-01 |
2023-11-01 |
Protiva Biotherapeutics Inc |
Nucleic acid-lipid particles, preparations containing them and their uses
|
FR2948035B1
(fr)
*
|
2009-07-20 |
2015-04-24 |
Centre Nat Rech Scient |
Procede de fabrication de capsules, capsules ainsi obtenues et utilisation desdites capsules
|
US8716464B2
(en)
|
2009-07-20 |
2014-05-06 |
Thomas W. Geisbert |
Compositions and methods for silencing Ebola virus gene expression
|
WO2011020023A2
(en)
|
2009-08-14 |
2011-02-17 |
Alnylam Pharmaceuticals, Inc. |
Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
|
EP2480668A2
(en)
|
2009-09-23 |
2012-08-01 |
Protiva Biotherapeutics Inc. |
Compositions and methods for silencing genes expressed in cancer
|
WO2011056682A1
(en)
|
2009-10-27 |
2011-05-12 |
The University Of British Columbia |
Reverse head group lipids, lipid particle compositions comprising reverse headgroup lipids, and methods for the delivery of nucleic acids
|
CA2783372C
(en)
|
2009-12-07 |
2019-07-16 |
Muthiah Manoharan |
Compositions for nucleic acid delivery
|
WO2011075656A1
(en)
|
2009-12-18 |
2011-06-23 |
The University Of British Columbia |
Methods and compositions for delivery of nucleic acids
|
JP2013527856A
(ja)
|
2010-05-12 |
2013-07-04 |
プロチバ バイオセラピューティクス インコーポレイティッド |
陽イオン性脂質およびその使用方法
|
US10077232B2
(en)
|
2010-05-12 |
2018-09-18 |
Arbutus Biopharma Corporation |
Cyclic cationic lipids and methods of use
|
EP2575764B1
(en)
|
2010-06-03 |
2017-04-19 |
Alnylam Pharmaceuticals, Inc. |
Biodegradable lipids for the delivery of active agents
|
WO2012016188A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
WO2012016184A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
CA3060724A1
(en)
|
2010-11-05 |
2012-05-10 |
Genalyte, Inc. |
Optical analyte detection systems and methods of use
|
CN103201386A
(zh)
|
2010-11-09 |
2013-07-10 |
加利福尼亚大学董事会 |
皮肤穿透及细胞进入(space)肽及其使用方法
|
EP3202760B1
(en)
|
2011-01-11 |
2019-08-21 |
Alnylam Pharmaceuticals, Inc. |
Pegylated lipids and their use for drug delivery
|
WO2012109387A1
(en)
|
2011-02-08 |
2012-08-16 |
Halozyme, Inc. |
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
|
US20140112979A1
(en)
|
2011-07-04 |
2014-04-24 |
Statens Serum Institut |
Methods for producing liposomes
|
AU2012315965A1
(en)
|
2011-09-27 |
2014-04-03 |
Alnylam Pharmaceuticals, Inc. |
Di-aliphatic substituted PEGylated lipids
|
WO2013075132A1
(en)
|
2011-11-17 |
2013-05-23 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Therapeutic rna switches compositions and methods of use
|
EP2606897A1
(en)
|
2011-12-22 |
2013-06-26 |
Laboratorios Del. Dr. Esteve, S.A. |
Methods and compositions for the treatment of diseases caused by enveloped viruses
|
US9035039B2
(en)
|
2011-12-22 |
2015-05-19 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing SMAD4
|
BR112014020824B1
(pt)
|
2012-02-24 |
2022-10-04 |
Protiva Biotherapeutics Inc |
Lipídeo, partícula de lipídeo e composição farmacêutica
|
EP2825885B1
(en)
|
2012-03-12 |
2021-05-12 |
The Board of Trustees of the University of Illinois |
Optical analyte detection systems with magnetic enhancement
|
EP2666456A1
(en)
|
2012-05-21 |
2013-11-27 |
Natura Bisse International, S.A. |
Cometic compositions comprising magnetosomes and uses thereof
|
WO2014039533A2
(en)
|
2012-09-04 |
2014-03-13 |
Eleison Pharmaceuticals, Llc |
Preventing pulmonary recurrence of cancer with lipid-complexed cisplatin
|
WO2015011633A1
(en)
|
2013-07-23 |
2015-01-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for delivering messenger rna
|
KR101465365B1
(ko)
*
|
2013-10-15 |
2014-11-25 |
성균관대학교산학협력단 |
리포좀 내 고분자 충진된 다중 기능 복합 입자체 및 이의 제조방법
|
KR101638156B1
(ko)
|
2013-10-29 |
2016-07-08 |
가톨릭대학교 산학협력단 |
C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물
|
DK3186281T3
(da)
|
2014-08-28 |
2019-06-11 |
Halozyme Inc |
Kombinationsterapi med et hyaluronan-nedbrydende enzym og en immun-checkpoint-inhibitor
|
WO2016054421A1
(en)
|
2014-10-02 |
2016-04-07 |
Protiva Biotherapeutics, Inc |
Compositions and methods for silencing hepatitis b virus gene expression
|
WO2016100716A1
(en)
|
2014-12-18 |
2016-06-23 |
Vasant Jadhav |
Reversirtm compounds
|
JP6316182B2
(ja)
|
2014-12-19 |
2018-04-25 |
富士フイルム株式会社 |
リポソームの製造方法及びリポソーム製造装置
|
EA201791437A1
(ru)
|
2014-12-31 |
2017-12-29 |
Лантеус Медикал Имэджинг, Инк. |
Композиции микросфер c инкапсулированным в липиде газом и соответствующие способы
|
EP4212148A1
(en)
|
2015-05-26 |
2023-07-19 |
Plumb Pharmaceuticals, Inc. |
Liposome loading
|
WO2016197132A1
(en)
|
2015-06-04 |
2016-12-08 |
Protiva Biotherapeutics Inc. |
Treating hepatitis b virus infection using crispr
|
EP3329003A2
(en)
|
2015-07-29 |
2018-06-06 |
Arbutus Biopharma Corporation |
Compositions and methods for silencing hepatitis b virus gene expression
|
EP3335028A1
(en)
|
2015-08-11 |
2018-06-20 |
Scintillon Institute for Biomedical and Bioenergy Research |
Optical analyses of particles and vesicles
|
US10363226B2
(en)
|
2015-08-12 |
2019-07-30 |
North Carolina State University |
Platelet membrane-coated drug delivery system
|
KR20240064009A
(ko)
|
2016-01-08 |
2024-05-10 |
더 리전트 오브 더 유니버시티 오브 캘리포니아 |
화물 전달용 지질 2중층 코팅물을 가진 메조다공성 실리카 나노입자
|
US10188749B2
(en)
|
2016-04-14 |
2019-01-29 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
EP4166161A1
(en)
|
2016-04-14 |
2023-04-19 |
Fred Hutchinson Cancer Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
TWI740937B
(zh)
|
2016-05-04 |
2021-10-01 |
美商藍瑟斯醫學影像公司 |
用於製備超音波顯影劑之裝置及方法
|
CN109563511A
(zh)
|
2016-06-30 |
2019-04-02 |
阿布特斯生物制药公司 |
用于递送信使rna的组合物和方法
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|
JP7295360B2
(ja)
|
2016-12-21 |
2023-06-21 |
モナーク・バイオサイエンシズ・インコーポレイテッド |
固形腫瘍細胞及びエスケープバリアントを治療するための足場
|
JP7348063B2
(ja)
|
2017-01-05 |
2023-09-20 |
フレッド ハッチンソン キャンサー センター |
ワクチン効力を改善するためのシステム及び方法
|
TW201936201A
(zh)
|
2017-12-14 |
2019-09-16 |
美商堅固生物科技公司 |
基因之非病毒生產及遞送
|
AU2020295807A1
(en)
|
2019-06-20 |
2022-02-17 |
Janssen Sciences Ireland Unlimited Company |
Lipid nanoparticle or liposome delivery of hepatitis B virus (HBV) vaccines
|
US20210023023A1
(en)
*
|
2019-07-25 |
2021-01-28 |
Vasayo, Llc |
Liposomal nutraceutical compositions and methods of making the same
|
WO2022133230A1
(en)
|
2020-12-18 |
2022-06-23 |
Janssen Pharmaceuticals, Inc. |
Combination therapy for treating hepatitis b virus infection
|
US11033495B1
(en)
|
2021-01-22 |
2021-06-15 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11357727B1
(en)
|
2021-01-22 |
2022-06-14 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
US11278494B1
(en)
|
2021-01-22 |
2022-03-22 |
Pacira Pharmaceuticals, Inc. |
Manufacturing of bupivacaine multivesicular liposomes
|
EP4312536A1
(en)
|
2021-04-01 |
2024-02-07 |
Vestaron Corporation |
Liposome formulations for pesticide delivery and methods for producing and using the same
|
WO2023018990A2
(en)
|
2021-08-12 |
2023-02-16 |
Life Technologies Corporation |
Lipids for nucleic acid delivery
|
WO2023144792A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Poly(alkyloxazoline)-lipid conjugates and lipid particles containing same
|
WO2023144798A1
(en)
|
2022-01-31 |
2023-08-03 |
Genevant Sciences Gmbh |
Ionizable cationic lipids for lipid nanoparticles
|
WO2023233290A1
(en)
|
2022-05-31 |
2023-12-07 |
Janssen Sciences Ireland Unlimited Company |
Rnai agents targeting pd-l1
|
NL2035417A
(en)
|
2022-07-19 |
2024-01-26 |
Coty Inc |
Cosmetic composition
|
WO2024031051A1
(en)
|
2022-08-05 |
2024-02-08 |
Life Technologies Corporation |
Lipids for nucleic acid delivery
|